Last updated: 2026-09-28 15:33:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Rapid Micro Biosystems, Inc. (RPID) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $1.10, with a market capitalization of $55.68M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.09 to $4.94. This page covers its latest market performance, valuation, price trends and company information.
$55.68M | |
$1.13 | |
$27.04 | |
$0.58 | |
$1.11 | |
65.07K | |
256.22K | |
-- | |
$4.94 | |
$1.09 | |
-- | |
-- |
Rapid Micro Biosystems, Inc. (RPID) is currently trading at $1.10 as of 2026-09-28 15:31:00, down 1.35% ($0.02) from the previous close of $1.11
During today's regular trading session, RPID has traded between $0.58 and $27.04, with a trading volume of 65.07K shares. The current price is near the lower end of today's range.
Over the past seven days, Rapid Micro Biosystems, Inc. (RPID) moved from $1.09 to $1.10, representing a gain of 0.46% ($0.00).
The stock traded between $1.09 and $1.20 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 451.78 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.3%
RPID is currently trading at $1.10, placing it 0.3% of the way from its 52-week low of $1.09 to its 52-week high of $4.94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 171 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Rapid Micro Biosystems, Inc. (RPID) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.